Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Silvia Gutierrez-Cossío"'
Autor:
Belén Blanco, José A. Pérez-Simón, Luis I. Sánchez-Abarca, Teresa Caballero-Velazquez, Silvia Gutierrez-Cossío, Pilar Hernández-Campo, María Díez-Campelo, Carmen Herrero-Sanchez, Concepción Rodriguez-Serrano, Carlos Santamaría, Fermín M. Sánchez-Guijo, Consuelo del Cañizo, Jesús F. San Miguel
Publikováno v:
Haematologica, Vol 94, Iss 7 (2009)
Background In vitro depletion of alloreactive T cells using the proteasome inhibitor bortezomib is a promising approach to prevent graft-versus-host disease after allogeneic stem cell transplantation. We have previously described the ability of borte
Externí odkaz:
https://doaj.org/article/4f97eaf78a574f4b88980ce89c2d40b4
Autor:
Carmen Herrero-Sánchez, Belén Blanco, Pilar Hernandez-Campo, Concepción Rodríguez-Serrano, Fermín Sánchez-Guijo, María Díez-Campelo, José A. Pérez-Simón, Teresa Caballero-Velázquez, Carlos Santamaría, Luis Ignacio Sánchez-Abarca, Consuelo del Cañizo, Jesús F. San Miguel, Silvia Gutierrez-Cossío
Publikováno v:
UVaDOC. Repositorio Documental de la Universidad de Valladolid
instname
instname
Producción Científica
Background In vitro depletion of alloreactive T cells using the proteasome inhibitor bortezomib is a promising approach to prevent graft-versus-host disease after allogeneic stem cell transplantation. We have previously d
Background In vitro depletion of alloreactive T cells using the proteasome inhibitor bortezomib is a promising approach to prevent graft-versus-host disease after allogeneic stem cell transplantation. We have previously d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4d53fa7c68fb02e54d3100d4651cea2
https://europepmc.org/articles/PMC2704308/
https://europepmc.org/articles/PMC2704308/
